Optimizing Patient Care in NSCLC: A Targeted Patient-Centered Approach

Daniel Morgensztern, MD, is an associate professor at Washington University School of Medicine and the director of thoracic medical oncology. He graduated from FTE Souza Marques in Brazil followed by residency in internal medicine and fellowship in hematology-oncology at the University of Miami School of Medicine. Among his awards are the first place in the Doctor’s Dilemma Competition from the American College of Physicians in Florida (2000), Young Investigator Award from the American Society of Clinical Oncology (2003), American Society of Clinical Oncology Merit Award (2004), David S. Fischer Award for Outstanding Teaching and Mentoring Fellows in Medical Oncology at the Yale Cancer Center (2013), and Teacher of the Year award for the Hematology-Oncology Fellowship Program at Washington University (2015).

 

 

 

Jared Weiss, MD, is an assistant professor of medicine at the University of North Carolina Lineberger Comprehensive Cancer Center in Chapel Hill, North Carolina. He completed his BS in neuroscience at Brown University in Providence, Rhode Island; his Doctor of Medicine at Yale University School of Medicine in New Haven, Connecticut; his residency in internal medicine at Beth Israel Deaconess Medical Center in Boston; and his fellowship at the Hospital of the University of Pennsylvania in Philadelphia.

 

Dr. Weiss’s teaching within the university is integrated with his clinical practice and research efforts. He is an active clinical trialist; he is currently the lead principal investigator (PI) on seven investigator-initiated trials and site PI on numerous others. Previous research has resulted in dozens of papers and abstracts.

 

Dr. Weiss is active in the area of direct patient education. He has generated more than 50 videos and articles for the cancer information website CancerGrace.org and also serves on its board. Dr. Weiss is an active advocate for lung cancer patients and serves on the board of the Lung Cancer Initiative of North Carolina. He is also active in physician education, travelling nationally as a discussant at American Society of Clinical Oncology and American Thoracic Society as well as delivering numerous continuing medical education lectures.

H. Jack West, MD received a master of philosophy in experimental biology from Cambridge University in England on a Fulbright Scholarship and a medical degree (magna cum laude) from Harvard Medical School in Boston, where he also conducted research as a Howard Hughes Medical Student Fellow. Dr. West’s postdoctoral training included an internship and residency in internal medicine at Brigham and Women’s Hospital in Boston and a fellowship in medical oncology at the Fred Hutchinson Cancer Research Center/University of Washington in Seattle. He joined Swedish Cancer Institute in late 2002 and continues to work there as a medical oncologist and serve as medical director of the Thoracic Oncology Program.

 

Dr. West has published numerous articles in the peer-reviewed literature and has authored several book chapters. He also now serves as the web editor of JAMA Oncology and is on the editorial boards of Journal of Clinical Oncology, Journal of Medicine, Clinical Lung Cancer, and Journal of Thoracic Disease, in addition to serving as an author of multiple lung cancer-related sections of UpToDate and as a reviewer for more than a dozen professional journals. Dr. West leads a wide range of clinical trials and has been actively involved with the SWOG Lung Cancer Committee on multiple recent studies, on which he serves as study coordinator/principal investigator.

 

Finally, Dr. West founded and continues to run the nonprofit organization GRACE: Global Resource for Advancing Cancer Education, as a source of timely, free information for patients and caregivers dealing with cancer. GRACE currently receives more than 50,000 visits per month from over 100 countries around the world.